| Literature DB >> 25826237 |
Niamh Mc Devitt1,2, Louise Gallagher3,4,5,6,7, Richard B Reilly8,9,10,11.
Abstract
Autism Spectrum Disorder (ASD) and Fragile X syndrome (FXS) are neurodevelopmental disorders with different but potentially related neurobiological underpinnings, which exhibit significant overlap in their behavioural symptoms. FXS is a neurogenetic disorder of known cause whereas ASD is a complex genetic disorder, with both rare and common genetic risk factors and likely genetic and environmental interaction effects. A comparison of the phenotypic presentation of the two disorders may highlight those symptoms that are more likely to be under direct genetic control, for example in FXS as opposed to shared symptoms that are likely to be under the control of multiple mechanisms. This review is focused on the application and analysis of electroencephalography data (EEG) in ASD and FXS. Specifically, Event Related Potentials (ERP) and resting state studies (rEEG) studies investigating ASD and FXS cohorts are compared. This review explores the electrophysiological similarities and differences between the two disorders in addition to the potentially associated neurobiological mechanisms at play. A series of pertinent research questions which are suggested in the literature are also posed within the review.Entities:
Year: 2015 PMID: 25826237 PMCID: PMC4493458 DOI: 10.3390/brainsci5020092
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
A comparison of Fragile X Syndrome (FXS) and Autism Spectrum Disorder (ASD) through neuroanatomy and neuroimaging studies.
| Study (year) | Disorder Studied | Method Employed | Subject Number ( | Regions Investigated | Abnormality |
|---|---|---|---|---|---|
| Reiss (1988) [ | FXS | MRI | FXS, 4 males. | Cerebellum | Significantly ↓ size of posterior portion of the cerebellar vermis. |
| Greco (2011) [ | FXS | Post mortem neuropathological study. | FXS, 3 males. | Cerebellum and hippocampus (HC). | Significant morphological changes in both the cerebellum and HC. |
| Meguid | FXS | MRI | FXS, 11 males. | Cortical morphology | ↑ in whole hemispheric and lobar cortical volume. |
| Courchesne | ASD | MRI | ASD 60 participants | Total Brain volume (TBV) | ↑ TBV in 90% of ASD group 2–4 years. |
| Carper | ASD | MRI | ASD, 38 males | Gray Matter Volume (GMV) | 2–3 years, GM and White Matter (WM) hyperplasia (20% enlargement) no difference in 9–11.5 years. |
| Redcay & Courchesne 2005 [
| ASD | Meta-analysis of 15 studies. | ASD, 49 males. | TBV | ↓ in brain size at birth, dramatic ↑ within 1st year, plateau by adulthood. |
| Dalton | ASD & FXS | MRI | 9 FXS, 14 ASD, 15 controls. | Fusiform Gyrus (FG). | Both groups ↓ activation in FG associated with looking at faces. ↑ Activation in FXS compared with ASD and controls in general. |
| Hazlett | FXS & ASD | MRI | FXS, 52 males, ASD 63 males, Developmental Delay (DD) 19 males, Controls 31 males. | Brain volume in substructures associated with behavioural features of ASD. | FXS + ASD had substantially enlarged CN volume and smaller amygdala (AMY) than FXS only. ASD subjects modest ↑ in CN volumes, compared to controls more robust ↑ in AMY volume. |
| Wilson, (2009) [ | FXS & ASD. | MRI | FXS 10 (7 male), ASD 10 (8 male) and Controls 10 (7 male). | Voxel Based Morphometry (VBM) to identify volumetric changes. | Regional GMV in frontal, parietal, temporal and cingulate gyri as well as CN and CRB, were larger in FXS group relative to ASD. |
| Hoeft (2011) [ | FXS & ASD | MRI | 52 FXS, 63 ASD | Whole brain morphometric patterns. | Generally ↑ volume in ASD compared to controls, ASD in turn had ↑ volume compared to FXS. |